rosiglitazone has been researched along with Marfan Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, RG; Auwerx, J; Boucher, P; Herz, J; Li, WP; Matz, RL; Takayama, Y | 1 |
1 other study(ies) available for rosiglitazone and Marfan Syndrome
Article | Year |
---|---|
LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome.
Topics: Animals; Atherosclerosis; Blotting, Western; Low Density Lipoprotein Receptor-Related Protein-1; Marfan Syndrome; Mice; Mice, Transgenic; Microscopy, Fluorescence; Platelet-Derived Growth Factor; Rosiglitazone; Signal Transduction; Smad Proteins; Thiazolidinediones; Transforming Growth Factor beta; Tunica Intima | 2007 |